Express Scripts Includes Innovative Cholesterol-Lowering Drugs on National Preferred Formulary

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Express Scripts Includes Innovative Cholesterol-Lowering Drugs on National Preferred Formulary

Express Scripts (ESRX) Includes Praluent and Repatha on National Preferred Formulary

October 6, 2015 5:06 PM EDT

To ensure clinically appropriate, cost-effective use of two new cholesterol-lowering drugs, Express Scripts (NASDAQ: ESRX) today announced it will include both Praluent and Repatha on its National Preferred Formulary, the nation's largest formulary covering approximately 25 million Americans.

"As always, we make sure our patients access the right medications at the best possible price with the greatest level of care," said Dr. Steve Miller, Senior Vice President and Chief Medical Officer of Express Scripts. "Since these new medications were approved a few months ago, our pharmacy experts have worked with medical professionals and... More